Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease
Open Access
- 2 June 2020
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 141 (22), 1826-1828
- https://doi.org/10.1161/circulationaha.120.045826
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and DiabetesJournal of the American College of Cardiology, 2019
- Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer DiseaseStroke, 2019
- Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering TherapiesJAMA Cardiology, 2018
- Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) LevelsJournal of the American College of Cardiology, 2016
- Genetic Associations with Valvular Calcification and Aortic StenosisNew England Journal of Medicine, 2013